Safety and Efficacy of Low-Dose Bexarotene and PUVA in the Treatment of Patients with Mycosis Fungoides

被引：0

作者：

Evangelia Papadavid

Christina Antoniou

Vassiliki Nikolaou

Marina Siakantaris

Theodoros P. Vassilakopoulos

Alexandros Stratigos

Nikolaos Stavrianeas

Andreas Katsambas

机构：

[1] Athens University Medical School,1st Department of Dermatology

[2] Skin Lymphoma Clinic,2nd Department of Dermatology

[3] A Sygros Hospital,1st Department of Internal Medicine

[4] Athens University Medical School,Haematology

[5] ATTIKON University General Hospital,undefined

[6] Athens University Medical School,undefined

[7] Laikon General Hospital,undefined

来源：

American Journal of Clinical Dermatology | 2008年 / 9卷

关键词：

Fenofibrate; Mycosis Fungoides; Bexarotene; Overall Response; Immune Response Modifier;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Background:The new rexinoid bexarotene is a retinoid X receptor antagonist and immune response modifier. Although combinations of oral bexarotene and psoralen plus UVA (PUVA) have been tried in patients with all stages of mycosis fungoides (MF), the dosage of bexarotene used in these combination regimens has been variable.

引用

页码：169 / 173

页数：4

共 50 条

[1] Safety and efficacy of low-dose bexarotene and PUVA in the treatment of patients with mycosis fungoides
Papadavid, Evangelia
Antoniou, Christina
Nikolaou, Vassiliki
Siakantaris, Marina
Vassilakopoulos, Theodoros P.
Stratigos, Alexandros
Stavrianeas, Nikolaos
Katsambas, Andreas
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2008, 9 (03) : 169 - 173
[2] TREATMENT OF MYCOSIS FUNGOIDES WITH PUVA AND BEXAROTENE
Ortiz-Romero, Pablo L.
Elena Sanchez-Largo, Ma
Sanz, Henar
Garcia-Romero, Diana
Rosales, Belen
Valverde, Ricardo
Arrue, Itziar
Polo, Isabel
Ruiz, Diana
Fernandez-Herrera, Jesus
Vanaclocha, Francisco
ACTAS DERMO-SIFILIOGRAFICAS, 2006, 97 (05): : 311 - 318
[3] Successful treatment of a folliculotropic mycosis fungoides with bexarotene and PUVA
Kroenke, Anna
Schlaak, Max
Arin, Meral
Mauch, Cornelia
Kurschat, Peter
EUROPEAN JOURNAL OF DERMATOLOGY, 2012, 22 (02) : 259 - 260
[4] Juvenile mycosis fungoides treated with bexarotene and PUVA
Rodriguez-Vazquez, Maria
Garcia-Arpa, Monica
Gonzalez-Garcia, Jesus
INTERNATIONAL JOURNAL OF DERMATOLOGY, 2007, 46 (01) : 99 - 102
[5] Results of a prospective phase II trial with oral low-dose bexarotene plus photochemotherapy (PUVA) in refractory and/or relapsed patients with mycosis fungoides
Serena Rupoli
Lucia Canafoglia
Gaia Goteri
Pietro Leoni
Giuliano Brandozzi
Irene Federici
Giorgia Micucci
Federica Giantomassi
Giorgio Mozzicafreddo
Renato Alterini
Giorgio Filosa
Giuseppe Ricotti
Marco Simonacci
Anna Rita Scortechini
Antonio Zizzi
Nicola Pimpinelli
European Journal of Dermatology, 2016, 26 : 13 - 20
[6] Results of a prospective phase II trial with oral low-dose bexarotene plus photochemotherapy (PUVA) in refractory and/or relapsed patients with mycosis fungoides
Rupoli, Serena
Canafoglia, Lucia
Goteri, Gaia
Leoni, Pietro
Brandozzi, Giuliano
Federici, Irene
Micucci, Giorgia
Giantomassi, Federica
Mozzicafreddo, Giorgio
Alterini, Renato
Filosa, Giorgio
Ricotti, Giuseppe
Simonacci, Marco
Scortechini, Anna Rita
Zizzi, Antonio
Pimpinelli, Nicola
EUROPEAN JOURNAL OF DERMATOLOGY, 2016, 26 (01) : 13 - 20
[7] Granulomatous mycosis fungoides. Combination therapy with bexarotene and PUVA
Wirtz, M.
Helbig, D.
HAUTARZT, 2014, 65 (04): : 274 - 276
[8] Low-dose 2-chlorodeoxyadenosine for the treatment of mycosis fungoides
Trautinger, F
Schwarzmeier, J
Hönigsmann, H
Knobler, RM
ARCHIVES OF DERMATOLOGY, 1999, 135 (10) : 1279 - 1280
[9] Treatment of transformed mycosis fungoides with intermittent low-dose gemcitabine
Awar, Omar
Duvic, Madeleine
ONCOLOGY, 2007, 73 (1-2) : 130 - 135
[10] Bexarotene plus PUVA plus radiation combination therapy for mycosis fungoides
Coors, Esther
DERMATOLOGIC CLINICS, 2008, 26 (01) : 33 - 35

← 1 2 3 4 5 →